SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905718-22-000007
Filing Date
2022-01-03
Accepted
2022-01-03 17:45:54
Documents
1
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3464
  Complete submission text file 0000905718-22-000007.txt   4825
Mailing Address VIROPHARMA INCORP 405 EAGLEVIEW BLVD EXTON PA 19341
Business Address
WIKLER MATTHEW (Reporting) CIK: 0001195414 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38022 | Film No.: 22503276

Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-484-8805
Matinas BioPharma Holdings, Inc. (Issuer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations